Phase Ⅰ/Ⅱ Study of the HS-10365 in Patients With Advanced Solid Tumors
Clinical trial NCT05207787 · UNKNOWN
Trial details
- NCT number
- NCT05207787
- Sponsor
- Jiangsu Hansoh Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-09
- Primary completion
- 2024-04-30
- Enrollment
- 306
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.